AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a technology platform...
AVITA Therapeutics, Inc. (NASDAQ: RCEL) (ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
AVITA Medical Limited (ASX: AVH) (NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical...
AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) today announced that management will present virtually at the upcoming Jefferies Virtual...
AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) today announced that management will participate virtually in the 1-on-1 meetings at the...
AVITA Medical Limited (Company) (ASX:AVH) (NASDAQ:RCEL) is pleased to announce that the Australian Securities and Investments Commission (ASIC...
AVITA Medical Limited (Company) (ASX:AVH, NASDAQ:RCEL) is pleased to announce that the Federal Court of Australia (Court) has today approved...
U.S. RECELL® System product sales of A$5.81M for fiscal third quarter AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine...
Intention to establish primary listing on NASDAQ with continued (secondary) listing on ASX AVITA Medical Limited (Company) (ASX: AVH, NASDAQ:...
AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical...
Abstracts Highlighting RECELL Clinical and Health Economic Benefits Included in Journal of Burn Care & Research Supplement AVITA Medical...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.